BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 15956396)

  • 21. Characterization of two Campylobacter jejuni strains for use in volunteer experimental-infection studies.
    Poly F; Read TD; Chen YH; Monteiro MA; Serichantalergs O; Pootong P; Bodhidatta L; Mason CJ; Rockabrand D; Baqar S; Porter CK; Tribble D; Darsley M; Guerry P
    Infect Immun; 2008 Dec; 76(12):5655-67. PubMed ID: 18809665
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlation between genotypic diversity, lipooligosaccharide gene locus class variation, and caco-2 cell invasion potential of Campylobacter jejuni isolates from chicken meat and humans: contribution to virulotyping.
    Habib I; Louwen R; Uyttendaele M; Houf K; Vandenberg O; Nieuwenhuis EE; Miller WG; van Belkum A; De Zutter L
    Appl Environ Microbiol; 2009 Jul; 75(13):4277-88. PubMed ID: 19411422
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of lipooligosaccharide biosynthesis genes of Campylobacter jejuni strains with varying abilities to colonize the chicken gut and to invade Caco-2 cells.
    Müller J; Meyer B; Hänel I; Hotzel H
    J Med Microbiol; 2007 Dec; 56(Pt 12):1589-1594. PubMed ID: 18033824
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Allelic diversity and recombination in Campylobacter jejuni.
    Suerbaum S; Lohrengel M; Sonnevend A; Ruberg F; Kist M
    J Bacteriol; 2001 Apr; 183(8):2553-9. PubMed ID: 11274115
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multilocus sequence typing system for Campylobacter jejuni.
    Dingle KE; Colles FM; Wareing DR; Ure R; Fox AJ; Bolton FE; Bootsma HJ; Willems RJ; Urwin R; Maiden MC
    J Clin Microbiol; 2001 Jan; 39(1):14-23. PubMed ID: 11136741
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Co-infection with two different Campylobacter jejuni strains in a patient with the Guillain-Barré syndrome.
    Godschalk PC; Gilbert M; Jacobs BC; Kramers T; Tio-Gillen AP; Ang CW; Van den Braak N; Li J; Verbrugh HA; Van Belkum A; Endtz HP
    Microbes Infect; 2006 Jan; 8(1):248-53. PubMed ID: 16213180
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Campylobacter sialyltransferase gene polymorphism directs clinical features of Guillain-Barré syndrome.
    Yuki N
    J Neurochem; 2007 Nov; 103 Suppl 1():150-8. PubMed ID: 17986150
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of genomic differences between Campylobacter jejuni subsp. jejuni and C. jejuni subsp. doylei at the nap locus leads to the development of a C. jejuni subspeciation multiplex PCR method.
    Miller WG; Parker CT; Heath S; Lastovica AJ
    BMC Microbiol; 2007 Feb; 7():11. PubMed ID: 17328805
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lipooligosaccharide locus classes and putative virulence genes among chicken and human Campylobacter jejuni isolates.
    Ellström P; Hansson I; Nilsson A; Rautelin H; Olsson Engvall E
    BMC Microbiol; 2016 Nov; 16(1):116. PubMed ID: 27871232
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Campylobacter gene polymorphism as a determinant of clinical features of Guillain-Barré syndrome.
    Koga M; Takahashi M; Masuda M; Hirata K; Yuki N
    Neurology; 2005 Nov; 65(9):1376-81. PubMed ID: 16162859
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of lipooligosaccharide-biosynthetic loci of Campylobacter jejuni reveals new lipooligosaccharide classes: evidence of mosaic organizations.
    Parker CT; Gilbert M; Yuki N; Endtz HP; Mandrell RE
    J Bacteriol; 2008 Aug; 190(16):5681-9. PubMed ID: 18556784
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic characterization of Campylobacter jejuni O:41 isolates in relation with Guillain-Barré syndrome.
    Wassenaar TM; Fry BN; Lastovica AJ; Wagenaar JA; Coloe PJ; Duim B
    J Clin Microbiol; 2000 Feb; 38(2):874-6. PubMed ID: 10655404
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sequence typing confirms that Campylobacter jejuni strains associated with Guillain-Barré and Miller-Fisher syndromes are of diverse genetic lineage, serotype, and flagella type.
    Dingle KE; Van Den Braak N; Colles FM; Price LJ; Woodward DL; Rodgers FG; Endtz HP; Van Belkum A; Maiden MC
    J Clin Microbiol; 2001 Sep; 39(9):3346-9. PubMed ID: 11526174
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship of bacterial strains to clinical syndromes of Campylobacter-associated neuropathies.
    Kimoto K; Koga M; Odaka M; Hirata K; Takahashi M; Li J; Gilbert M; Yuki N
    Neurology; 2006 Nov; 67(10):1837-43. PubMed ID: 17130419
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lipooligosaccharide of Campylobacter jejuni prevents myelin-specific enteral tolerance to autoimmune neuritis--a potential mechanism in Guillain-Barre syndrome?
    Jung S; Zimmer S; Lüneberg E; Frosch M; Karch H; Korn T; Toyka KV
    Neurosci Lett; 2005 Jun 10-17; 381(1-2):175-8. PubMed ID: 15882812
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Campylobacter jejuni cst-II polymorphisms and association with development of Guillain-Barré syndrome.
    Hye JB; Nachamkin I
    Neurology; 2007 May; 68(19):1633-4. PubMed ID: 17485654
    [No Abstract]   [Full Text] [Related]  

  • 37. Characterization of clinical Campylobacter jejuni isolates with special emphasis on lipooligosaccharide locus class, putative virulence factors and host response.
    Ellström P; Feodoroff B; Hänninen ML; Rautelin H
    Int J Med Microbiol; 2013 Apr; 303(3):134-9. PubMed ID: 23528202
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [PCR-RFLP for Campylobacter jejuni subtyping].
    Giacoboni G; Echeverría MG; Perfumo C
    Rev Argent Microbiol; 2005; 37(2):81-3. PubMed ID: 16178461
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The sialic acid residue is a crucial component of C. jejuni lipooligosaccharide ganglioside mimicry in the induction Guillain-Barré syndrome.
    Xiang SL; Zhong M; Cai FC; Deng B; Zhang XP
    J Neuroimmunol; 2006 May; 174(1-2):126-32. PubMed ID: 16567003
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Campylobacter DNA is present in circulating myelomonocytic cells of healthy persons and in persons with Guillain-Barré syndrome.
    Van Rhijn I; Bleumink-Pluym NM; Van Putten JP; Van den Berg LH
    J Infect Dis; 2002 Jan; 185(2):262-5. PubMed ID: 11807702
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.